Home | Welcome to Contract Pharma   
Last Updated Thursday, April 24 2014
Print RSS Feed

Breaking News

Gil Roth
July 14, 2011
OSDrC delivery tech adds to Catalent's oral solid dosage offerings  Read More »
Gil Roth
July 14, 2011
Hoyes to lead U.S. unit  Read More »
Gil Roth
July 14, 2011
New center in KS to provide study recruitment, medical management, oversight in CNS studies  Read More »
July 13, 2011
Sensient Pharmaceutical Coating Systems has expanded its pharmaceutical operations into Canada.  Read More »
July 13, 2011
Eman Albazzaz has been appointed executive director of Regulatory Affairs to lead regulatory and pharmacovigilance efforts for Advanced Clinical.   Read More »
July 13, 2011
Aslan Pharmaceuticals and Array BioPharma have entered into a license agreement to develop Array’s HER2/EGFR inhibitor, ARRY-543, currently in Phase II development for solid tumors.  Read More »
Gil Roth
July 13, 2011
Griffiths to run Swiss business  Read More »
July 13, 2011
Particle Sciences, Inc. (PSI) and Absorption Systems have formed a partnership to provide clients with enhanced drug development services by integrating preclinical pharmacokinetic data into the dosage form development.   Read More »
July 13, 2011
Chartwell Pharmaceuticals is now a registered pharmaceutical manufacturer with the FDA, effective March 15, 2011.  Read More »
July 12, 2011
PRA has created a legal entity in Bulgaria to support growth and expansion of operations in the region.  Read More »
July 12, 2011
Companies collaborate on second candidate for MANF-based therapeutic for the treatment of the beta cell destruction at the root of diabetes.  Read More »

July 12, 2011
Octagon adds Content Manager and Document Publisher to Submission Manager as the next applications for its Quantum platform.   Read More »
July 12, 2011
Mylan's Matrix Laboratories Ltd. entered an expanded licensing agreement with Gilead Sciences for the rights to produce and market generic versions of three Gilead HIV/AIDS therapies, currently in late-stage development.   Read More »
July 12, 2011
Norwich has added three business development leaders. Mitchell Winfree has been appointed vice president of business development and Gregory Downs and Bob Peoples have joined the company as directors of business development.  Read More »
July 11, 2011
Valeant to buy dermatology unit / CMO in the U.S. and Canada, for $425 million.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On